PDT Partners LLC Purchases Shares of 16,474 The Pennant Group, Inc. (NASDAQ:PNTG)

PDT Partners LLC acquired a new stake in shares of The Pennant Group, Inc. (NASDAQ:PNTG) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 16,474 shares of the company’s stock, valued at approximately $588,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. FMR LLC lifted its position in shares of The Pennant Group by 51.3% in the third quarter. FMR LLC now owns 2,528,512 shares of the company’s stock worth $90,268,000 after buying an additional 856,838 shares in the last quarter. Vanguard Group Inc. increased its stake in The Pennant Group by 4.3% in the 1st quarter. Vanguard Group Inc. now owns 1,859,679 shares of the company’s stock worth $36,505,000 after acquiring an additional 77,052 shares during the last quarter. Crewe Advisors LLC raised its holdings in shares of The Pennant Group by 1.6% during the 3rd quarter. Crewe Advisors LLC now owns 742,958 shares of the company’s stock worth $26,524,000 after acquiring an additional 11,927 shares in the last quarter. First Eagle Investment Management LLC boosted its position in shares of The Pennant Group by 2.1% during the 2nd quarter. First Eagle Investment Management LLC now owns 391,748 shares of the company’s stock valued at $9,085,000 after acquiring an additional 8,000 shares during the last quarter. Finally, De Lisle Partners LLP grew its holdings in shares of The Pennant Group by 7.6% in the third quarter. De Lisle Partners LLP now owns 343,340 shares of the company’s stock valued at $12,254,000 after purchasing an additional 24,321 shares in the last quarter. Institutional investors own 85.88% of the company’s stock.

The Pennant Group Stock Performance

Shares of NASDAQ:PNTG opened at $31.56 on Tuesday. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 0.58. The company has a market capitalization of $1.08 billion, a price-to-earnings ratio of 46.41, a PEG ratio of 3.18 and a beta of 2.02. The Pennant Group, Inc. has a 12 month low of $13.24 and a 12 month high of $37.13. The firm’s 50-day moving average is $33.17 and its 200 day moving average is $29.62.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on PNTG shares. Truist Financial upped their price target on shares of The Pennant Group from $34.00 to $38.00 and gave the company a “hold” rating in a research note on Monday, October 7th. Stephens reaffirmed an “overweight” rating and issued a $40.00 price target on shares of The Pennant Group in a report on Wednesday, October 9th. Oppenheimer upped their price objective on The Pennant Group from $34.00 to $37.00 and gave the company an “outperform” rating in a research report on Friday, November 8th. Finally, Royal Bank of Canada raised their price objective on The Pennant Group from $26.00 to $38.00 and gave the company an “outperform” rating in a research note on Wednesday, October 23rd.

The Pennant Group Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.